Today, Syndax Pharmaceuticals Inc (NASDAQ: SNDX) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that Syndax to Announce Fourth Quarter and Year-end 2023 Financial Results and Host Conference Call and Webcast on February 27, 2024.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Syndax Pharmaceuticals Inc is $1.79B. A total of 0.94 million shares were traded on the day, compared to an average of 1.52M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, SNDX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 10 BUYs and 11 SELLs from insiders. Insiders purchased 400,129 shares during that period but sold 400,706.

In the most recent transaction, Morrison Briggs sold 52,855 shares of SNDX for 18.27 per share on Aug 09. After the transaction, the Director now owns 17,836 company shares. In a previous transaction on Aug 02, Meury William sold 83,000 shares at 20.46 per share. SNDX shares that Director owns now total 48,000.

Among the insiders who sold shares, Morrison Briggs disposed of 52,855 shares on Jul 10 at a per-share price of $20.40. This resulted in the Director holding 17,836 shares of SNDX after the transaction. In another insider transaction, Goldan Keith A. sold 577 shares at $22.31 per share on Jun 13. Company shares held by the Chief Financial Officer now total 2,628.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for SNDX in the last 3 months, the mean price target is $35.25 with high estimates of $45.00 and low estimates of $23.00. In terms of 52-week highs and lows, SNDX has a high of $26.32 and a low of $11.22.

As of this writing, SNDX has an earnings estimate of -$0.99 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.84 per share and a lower estimate of -$1.15. The company reported an EPS of -$0.64 in the last quarter, which was 12.30% higher than expectations of -$0.73.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SNDX’s latest balance sheet shows that the firm has $446.83M in Cash & Short Term Investments as of fiscal 2021. There were $20.97M in debt and $20.68M in liabilities at the time. Its Book Value Per Share was $5.16, while its Total Shareholder’s Equity was $408.37M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SNDX is Buy with a score of 5.00.

Most Popular

Related Posts